Figure 2: Virus-specific versus broad-spectrum antiviral drugs

Uploaded by U.S. Government Accountability Office
License United States Government Work
Comments 0
Favorites 0
Views 948
Date uploaded 2023-10-23
Tags gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, antiviraldrugs, gao23105847, ai, artificialintelligence, app, antiviralprogramforpandemics, aspr, administrationforstrategicpreparednessandresponse, barda, biomedicaladvancedresearchanddevelopmentauthority, caresact, thecoronavirusaidreliefandeconomicsecurityact, cdc, centersfordiseasecontrolandprevention, covid19, coronavirusdisease2019, fda, foodanddrugadministration, hhs, departmentofhealthandhumanservices, ml, machinelearning, ncats, nationalcenterforadvancingtranslationalsciences, niaid, nationalinstituteofallergyandinfectiousdiseases, nih, nationalinstitutesofhealth, sarscov2, severeacuterespiratorysyndromecoronavirus2, who, worldhealthorganization
Visibility public